Ulcerative Colitis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

A Study to Evaluate Efficacy and Safety of MK-7240 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)
Conditions: Ulcerative Colitis Interventions: Drug: IV MK-7240; Drug: IV Placebo; Drug: SC MK-7240; Drug: SC Placebo Sponsors: Merck Sharp& Dohme LLC; PPD, Part of Thermo Fisher Scientific Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials

Prebiotics in Reducing Inflammation and Clinical Endpoints in Ulcerative Colitis (PRInCE-UC)
Condition:   Ulcerative Colitis Intervention:   Dietary Supplement: Prebiotic supplement Sponsors:   Royal Berkshire NHS Foundation Trust;   University of Reading Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials

Prebiotics in Reducing Inflammation and Clinical Endpoints in Ulcerative Colitis (PRInCE-UC)
Condition:   Ulcerative Colitis Interventions:   Dietary Supplement: 2'-Fucosyllactose;   Dietary Supplement: Placebo Sponsors:   Royal Berkshire NHS Foundation Trust;   University of Reading Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials

Prebiotics in Reducing Inflammation and Clinical Endpoints in Ulcerative Colitis (PRInCE-UC)
Conditions: Ulcerative Colitis Interventions: Dietary Supplement: 2 ' -Fucosyllactose; Dietary Supplement: Placebo Sponsors: Royal Berkshire NHS Foundation Trust; University of Reading Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials

A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis
Condition:   Colitis, Ulcerative Interventions:   Drug: JNJ-77242113;   Drug: Placebo Sponsor:   Janssen Research & Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials